Improving how doctors use a tool to predict the risk of pulmonary embolism.
Official title: Nudging Provider Adoption of Clinical Decision Support: Implementation of an EHR-Agnostic Pulmonary Embolism Risk Prediction Tool
Funded at New York University School of Medicine · NIH-11051198 · Data updated 2026-11-12
This study is looking at ways to help doctors in emergency rooms use a special tool that predicts the risk of blood clots in the lungs, so they can make better decisions about whether to do CT scans, which can sometimes be unnecessary and expose patients to extra radiation.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | April 1, 2024 |
| Project end | March 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $746,908 |
| NIH project number | 5R01HL169364-02 |
| Project ID | NIH-11051198 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients who are being evaluated for pulmonary embolism in emergency departments.
✕Less likely to help
Patients who are not being assessed for pulmonary embolism or those who do not require CT scans will not benefit from this research.
What this research studies
This research aims to enhance the adoption of a clinical decision support tool designed to predict the risk of pulmonary embolism (PE) before conducting CT scans in emergency departments. By integrating behavioral economics principles, the project seeks to create 'nudges' that encourage healthcare providers to use evidence-based guidelines more effectively, thereby reducing unnecessary CT scans and associated risks. The study will evaluate how these nudges can improve provider behavior and decision-making in real clinical settings. Ultimately, the goal is to minimize unnecessary radiation exposure and improve patient safety.
Why it matters
Potential benefit: If successful, this research could significantly reduce unnecessary CT scans for pulmonary embolism, lowering radiation exposure and associated health risks for patients.
How similar studies have gone: Previous research has shown that integrating behavioral insights into clinical decision-making tools can improve provider adherence to guidelines, suggesting a promising avenue for this approach.
Where this research is happening
-
New York University School of Medicine
New York, United States Active
Researchers
- Principal investigator: Richardson, Safiya — New York University School of Medicine
- Study coordinator: Richardson, Safiya
Related research
Other NIH-funded projects on the same topics.
-
AI-powered tool to better predict and manage acute pulmonary embolism
A new AI system uses imaging and patient data to improve how doctors predict short-term risk and tailor treatment for people with acute pulmonary embolism.
-
Endovascular vortex ultrasound to treat blood clots in the lungs
A new therapy uses a tiny ultrasound device inside the blood vessels to rapidly dissolve clots in the lungs of people with pulmonary embolism, aiming to reduce the need for high doses of clot-busting drugs.
-
Supplemental Oxygen for Pulmonary Embolism: A Mechanistic Look at How Oxygen Helps the Heart and Lungs
This NIH grant tests how giving extra oxygen affects lung pressure and heart strain in people with acute pulmonary embolism, with supportive animal studies to understand the biology.
-
Pulmonary embolism: catheter-directed clot removal for better outcomes
This trial tests whether delivering clot-dissolving medication directly to the lungs via a catheter helps people with submassive pulmonary embolism feel better and function better, with fewer bleeding risks.
-
Pulmonary embolism treatment with catheter-directed thrombus removal versus no catheter therapy
This study tests whether removing clot with a targeted catheter approach helps people with submassive pulmonary embolism feel better and move more easily, compared with not using catheter therapy.
-
Molecular and imaging study of blood clots and inflammation in pulmonary embolism
A research project uses a mouse model to understand how blood clots and inflammatory cells affect pulmonary embolism and its outcomes, with the goal of better diagnosis and treatment for people with PE.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.